AR2-56521-56423
3 vaccinations
12 coded responses
37 check-ins
12 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 850 / AZ
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Dose 1 — Moderna
-
2021-02-27
Registered in v-safe
-
2021-02-28
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus, Urticaria — Feeling: Poor · Site: Pain · Fatigue or tirednessFree text: Itching all over, after the hives have died down from the last two daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus, Urticaria — Feeling: GoodFree text: Itching. Leftover from hives on day 3 and 4.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus, Urticaria — Feeling: GoodFree text: Itching all over body, after hives on day 3 and 4MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Survey response — day 7, dose 1MedDRA: Pruritus, Urticaria — Feeling: GoodFree text: Itching all over torso, leftover from hives on day 3&4MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — day 14, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Injection site got sore again after being better.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-03-24
-
2021-03-26
Dose 2 — Moderna
-
2021-03-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: Urticaria — Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: HivesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus, Urticaria — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to workFree text: Itching, consequence of hives that have recededMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus, Urticaria — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Itching leftover from hivesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Pruritus, Urticaria — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Itching leftover from hivesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-24
-
2021-11-26
Dose 3 — Pfizer-BioNTech
-
2021-11-27
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-30
Survey response — days 1–6 daily, dose 3MedDRA: Pruritus, Urticaria — Feeling: Fair · Headache, Fatigue or tirednessFree text: Itching leftover from hivesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-01
-
2021-12-02
Survey response — days 1–6 daily, dose 3MedDRA: Pruritus, Rash, Urticaria — Feeling: GoodFree text: Itching leftover from rash hives.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Health check-in — day 7, dose 3Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-12-10
- 2021-12-17
- 2021-12-26
- 2021-12-31
-
2022-01-07
Survey response — day 42, dose 3MedDRA: Anosmia, Body temperature increased, COVID-19, Cough, Fatigue, Hypogeusia, Oropharyngeal pain, Sinus congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid. Sore throat, fatigue, sinus congestion, loss of smell, diminished taste, one day of fever@99 degrees, one day of mild cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-25
- 2022-05-27
- 2022-11-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Moderna | |
| 2 | 2021-03-26 | Moderna | |
| 3 | 2021-11-26 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Itching all over, after the hives have died down from the last two days
Systemic reaction (other): Itching. Leftover from hives on day 3 and 4.
Systemic reaction (other): Itching all over body, after hives on day 3 and 4
Release 4 — day 7, dose 1
Systemic reaction (other): Itching all over torso, leftover from hives on day 3&4
Release 5 — day 14, dose 1
Symptoms: Injection site got sore again after being better.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Hives
Systemic reaction (other): Itching, consequence of hives that have receded
Systemic reaction (other): Itching leftover from hives
Systemic reaction (other): Itching leftover from hives
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Itching leftover from hives
Systemic reaction (other): Itching leftover from rash hives.
Release 10 — day 42, dose 3
Symptoms: Covid. Sore throat, fatigue, sinus congestion, loss of smell, diminished taste, one day of fever@99 degrees, one day of mild cough.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release